Combination of APD668, a G protein-coupled receptor 119 agonist with linagliptin, a DPPIV inhibitor, prevents progression of steatohepatitis in a murine model of non-alcoholic steatohepatitis with diabetes.
Med Mol Morphol
; 52(1): 36-43, 2019 Mar.
Article
in En
| MEDLINE
| ID: mdl-29959534
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pyrazoles
/
Pyrimidines
/
Diabetes Mellitus, Experimental
/
Non-alcoholic Fatty Liver Disease
/
Linagliptin
Type of study:
Prognostic_studies
Limits:
Animals
Language:
En
Journal:
Med Mol Morphol
Journal subject:
BIOLOGIA MOLECULAR
/
PATOLOGIA
Year:
2019
Document type:
Article
Affiliation country:
India
Country of publication:
Japan